Acquisition of relenza for DHS antiviral stockpile
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- HSHQDC15D00016
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Office of Procurement Operations
Department of Homeland Security
- Task orders
- 5 $1,514,785 obligated
Award facts
- Combined order value
- $1,514,785 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 6% used
- $26,389,800.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- Funding agency
- Chief Human Capital Officer Department of Homeland Security
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This federal contract IDV was awarded by the U.S. Department of Homeland Security (DHS) to Glaxosmithkline, LLC, a foreign-owned pharmaceutical company, to procure the antiviral medication Relenza for DHS's antiviral stockpile. The single-award contract has a ceiling value of $26,389,800 and does not have a set-aside designation. Under this IDV, DHS has issued multiple delivery orders to Glaxosmithkline for the purchase of Relenza and the related antiviral medication Zanamivir, with orders ranging from $132,307.29 to $668,976 in value. The delivery orders specify firm fixed prices per course of the antiviral medications, with quantities ranging from 550 courses to 30,800 courses. The contract supports DHS's Countering Weapons of Mass Destruction efforts by ensuring availability of critical antiviral drugs as part of medical countermeasures and preparedness activities. Glaxosmithkline, as a global pharmaceutical company, has extensive experience providing a variety of vaccines, antivirals, and other medical products to multiple U.S. government agencies through both federal contracts and grants.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HSHQDC15D00016?
HSHQDC15D00016 was awarded to Glaxosmithkline, LLC by Office of Procurement Operations (Department of Homeland Security) on July 10, 2015.
How much is contract HSHQDC15D00016 worth?
Orders under HSHQDC15D00016 have obligated $1,514,785. HSHQDC15D00016's own ceiling is $26,389,800.
How many orders have been placed under contract HSHQDC15D00016?
5 orders have been placed under HSHQDC15D00016, the latest on July 13, 2019.
Which agency awarded contract HSHQDC15D00016?
Office of Procurement Operations (Department of Homeland Security) awarded HSHQDC15D00016, with funding from Chief Human Capital Officer (Department of Homeland Security).
Who can order from contract HSHQDC15D00016?
HSHQDC15D00016 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract HSHQDC15D00016 competed?
The extent of competition for HSHQDC15D00016 was not competed. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV